Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Squamous cell carcinoma of the colon with an elevated serum squamous cell carcinoma antigen responding to combination chemotherapy.

Copur S, Ledakis P, Novinski D, Mleczko KL, Frankforter S, Bolton M, Fruehling RM, VanWie E, Norvell M, Muhvic J.

Clin Colorectal Cancer. 2001 May;1(1):55-8.

PMID:
12445380
2.

[Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].

Li Q, Liu S, Liu H, Zhang J, Guo S, Wang L.

Zhonghua Fu Chan Ke Za Zhi. 2015 Feb;50(2):131-6. Chinese.

PMID:
25877611
3.

[The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer].

Meier W, Eiermann W, Stieber P, Fateh-Moghadam A, Hepp H.

Geburtshilfe Frauenheilkd. 1989 Dec;49(12):1050-5. German.

PMID:
2693187
4.

Squamous-cell carcinoma of the colon responsive to combination chemotherapy: report of two cases and review of the literature.

Juturi JV, Francis B, Koontz PW, Wilkes JD.

Dis Colon Rectum. 1999 Jan;42(1):102-9. Review.

PMID:
10211528
5.

The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.

de Bruijn HW, Duk JM, van der Zee AG, Pras E, Willemse PH, Boonstra H, Hollema H, Mourits MJ, de Vries EG, Aalders JG.

Tumour Biol. 1998;19(6):505-16.

PMID:
9817980
6.

Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.

Cho H, Nishiike S, Yamamoto Y, Takenaka Y, Nakahara S, Yasui T, Hanamoto A, Inohara H.

Auris Nasus Larynx. 2015 Oct;42(5):396-400. doi: 10.1016/j.anl.2015.02.009. Epub 2015 Feb 23.

PMID:
25721854
7.

The value of squamous cell carcinoma antigen in patients with locally advanced cervical cancer undergoing neoadjuvant chemotherapy.

Scambia G, Panici PB, Baiocchi G, Amoroso M, Foti E, Greggi S, Mancuso S.

Am J Obstet Gynecol. 1991 Feb;164(2):631-6.

PMID:
1992715
8.

Serum concentrations of squamous-cell carcinoma antigen and tissue polypeptide antigen in the follow-up of patients with vulvar cancer.

Hefler L, Frischmuth K, Heinze G, Sliutz G, Leodolter S, Reinthaller A, Kainz C, Tempfer C.

Int J Cancer. 1999 Oct 8;83(2):167-70.

9.

The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.

Li X, Zhou J, Huang K, Tang F, Zhou H, Wang S, Jia Y, Sun H, Ma D, Li S.

PLoS One. 2015 Apr 10;10(4):e0122361. doi: 10.1371/journal.pone.0122361. eCollection 2015.

10.

Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.

Esajas MD, Duk JM, de Bruijn HW, Aalders JG, Willemse PH, Sluiter W, Pras B, ten Hoor K, Hollema H, van der Zee AG.

J Clin Oncol. 2001 Oct 1;19(19):3960-6.

PMID:
11579117
11.

[Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].

Arlt A, Luckhaupt H, Hildmann H.

Laryngorhinootologie. 2000 Apr;79(4):207-12. German.

PMID:
10838684
12.

Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.

Kajiura S, Hosokawa A, Yoshita H, Ueda Y, Ueda A, Mihara H, Ando T, Fujinami H, Nishikawa J, Ogawa K, Minemura M, Sugiyama T.

Am J Clin Oncol. 2016 Feb;39(1):13-7. doi: 10.1097/COC.0000000000000018.

PMID:
24322336
13.

Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence.

Salvatici M, Achilarre MT, Sandri MT, Boveri S, Vanna Z, Landoni F.

Gynecol Oncol. 2016 Jul;142(1):115-119. doi: 10.1016/j.ygyno.2016.04.029. Epub 2016 May 6.

PMID:
27117922
14.

Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal.

Ajani JA, Carrasco CH, Jackson DE, Wallace S.

Am J Med. 1989 Aug;87(2):221-4. No abstract available.

PMID:
2527006
15.

[The course of squamous cell cancer antigen in chemotherapy as a prognostic criterion in cervix cancer].

Meier W, Stieber P, Fateh-Moghadam A, Eiermann W, Hepp H.

Gynakol Rundsch. 1989;29 Suppl 2:411-2. German. No abstract available.

PMID:
2613066
16.

Use of tumor markers in the management of head and neck cancer.

Rosati G, Riccardi F, Tucci A.

Int J Biol Markers. 2000 Apr-Jun;15(2):179-83.

PMID:
10883893
17.

Second-line combination chemotherapy with docetaxel and nedaplatin for Cisplatin-pretreated refractory metastatic/recurrent esophageal squamous cell carcinoma.

Jin J, Xu X, Wang F, Yan G, Liu J, Lu W, Li X, Tucker SJ, Zhong B, Cao Z, Wang D.

J Thorac Oncol. 2009 Aug;4(8):1017-21. doi: 10.1097/JTO.0b013e3181add9c7.

18.

[Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].

Zeng L.

Zhonghua Wai Ke Za Zhi. 1993 Mar;31(3):143-5. Chinese.

PMID:
8223022
19.

SCC antigen in malignant and nonmalignant squamous lesions.

Torre GC.

Tumour Biol. 1998;19(6):517-26. Review.

PMID:
9817981
20.

Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.

Huang EY, Huang YJ, Chanchien CC, Lin H, Wang CJ, Sun LM, Tseng CW, Tsai CC, Ou YC, Fu HC, Chen HC, Hsu HC, Wang CY.

Radiat Oncol. 2012 Jan 30;7:13. doi: 10.1186/1748-717X-7-13.

Supplemental Content

Support Center